Role of activation of the coagulation factor VIII in interaction with vWf, phospholipid, and functioning within the factor xase complex

Trends in Cardiovascular Medicine

Volumn 9, Issue 7, 1999, Pages 185-192

  Saenko, Evgueni L ^a,c   Shima, Midori ^b   Sarafanov, Andrey G ^a  

^a HOLLAND LABORATORY   (United States)

^b NARA MEDICAL UNIVERSITY   (Japan)

^c AMERICAN RED CROSS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0343962699     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(00)00019-0     Document Type: Review

References (60)

1. Arai M, Scandella D, Hoyer LW: 1989. Molecular basis of factor VIII inhibition by human antibodies. Antibodies that bind to the factor VIII light chain prevent the interaction of factor VIII with phospholipid. J Clin Invest 83:1978-1984.
2. Brinkman HJM, Mertens K, Holthuis J, et al.: 1999. The activation of human blood coagulation factor X on the surface of endothelial cells: A comparison with various vascular cells, platelets and monocytes. Br J Haematol 87:332-342.
3. Donath M-JSH, Lenting PJ, van Mourik JA, et al.: 1996. The role of cleavage of the light chain at positions arg1689 or arg1721 in subunit interaction and activation of human blood coagulation factor VIII. J Biol Chem 270:3648-3655.
4. Fay PJ: 1999. Regulation of Factor VIIIa in the Intrinsic Factor Xase. Thromb Haemost 82:193-200.
5. Fay PJ, Anderson MT, Chavin SI, et al.: 1986. The size of human factor VIII heterodimers and the effects produced by thrombin. Biochim Biophys Acta 871:268-278.
6. Fay PJ, Beattie T, Huggins CF, et al.: 1994. Factor VIIIa A2 subunit residues 558-565 represent a factor IXa interactive site. J Biol Chem 269:20,522-20,527.
7. Fay PJ, Beattie TL, Regan LM, et al.: 1996. Model for the factor VIIIa-dependent decay of the intrinsic factor Xase: Role of subunit dissociation and factor IXa-catalyzed proteolysis. J Biol Chem 271:6027-6032.
8. Fay PJ, Haidaris PJ, Huggins CF: 1993. Role of the COOH-terminal acidic region of Al subunit in A2 subunit retention in human factor VIIIa. J Biol Chem 268:17,861-17,866.
9. Fay PJ, Koshibu K: 1998. The A2 subunit of factor VIIIa modulates the active site of actor IXa. J Biol Chem 273:19,049-19,054.
10. a. J Biol Chem 267:13,246-13,250.
11. Fay PJ, Smudzin TM, Walker FJ: 1991. Activated protein C-catalyzed inactivation of human factor VIII and factor Villa. Identi-fication of cleavage sites and correlation of proteolysis with cofactor activity. J Biol Chem 266:20,139-20,145.
12. Foster PA, Fulcher CA, Houghten RA, et al.: 1990. Synthetic factor VIII peptides with amino acid sequences contained within the C2 domain of factor VIII inhibit factor VIII binding to phosphatidylserine. Blood 75:1999-2004.
13. Genest J, Cohn J. 1998. Plasma triglyceriderich lipoprotein and high density lipoproteins disorders associated with atherosclerosis. J Invest Med 46:351-358.
14. Gilbert GE, Arena AA: 1996. Activation of the factor VIIIa-factor IXa enzyme complex of blood coagulation by membranes containing phosphatidyl-L-serine. J Biol Chem 271:11,120-11,125.
15. Gilbert GE. Baleja JD: 1995. Membrane-binding peptide from the C2 domain of factor VIII forms an amphipathic structure as determined by NMR spectroscopy. Biochemistry 34:3022-3031.
16. Gilbert GE, Drinkwater D, Barter S, et al.: 1992. Specificity of phosphatidylserine-containing membrane binding sites for factor VIII. Studies with model membranes supported by glass microspheres (lipospheres). J Biol Chem 267:15,861-15,868.
17. Gilbert GE, Furie BC, Furie B: 1990. Binding of human factor VIII to phospholipid vesicles. J Biol Chem 265:815-822.
18. Healey J, Barrow RT, Tamim HM, et al.: 1999. Residues Glu2181-Val2243 contain a major determinant of the inhibitory epitope in the C2 domain of human factor VIII. Blood 92:3701-3709.
19. Hill-Eubanks DC, Lollar P: 1990. von Willebrand factor is a cofactor for thrombin-catalyzed cleavage of the factor VIII light chain. J Biol Chem 265:17,854-17,858.
20. Hill-Eubanks DC, Parker CG, Lollar P: 1989. Differential proteolytic activation of factor VIII-von Willebrand factor complex by thrombin. Proc Natl Acad Sci USA 86:6508-6512.
21. Kalafatis M, Rand MD, Mann KG: 1994. Factor Va-membrane interaction is mediated by two regions located on the light chain of the cofactor. Biochemistry 33:486-493.
22. 1689 detected by a novel ELISA. Br J Haematol 86:106-111.
23. Kaufman RJ, Pipe SW: 1999. Regulation of factor VIII expression and activity by von Willebrand factor. Thromb Haemost 82:201-208.
24. Kim SW, Quinn-Allen MA, Kane WH: 1999. Identification of functionally important amino acid residues within the C2 domain of human factor V using alanine scanning mutagenesis. Blood 92(Suppl 1):184a.
25. Koedam JA, Hamer RJ, Beeser-Visser NH, et al.: 1990. The effect of von Willebrand factor on activation of factor VIII by factor Xa. Eur J Biochem 189:229-234.
26. Lapan KA, Fay PJ: 1997. Localization of a factor X interactive site in the A1 subunit of factor VIIIa. J Biol Chem 272:2082-2088.
27. Lapan KA, Fay PJ: 1998. Interaction of the A1 subunit of factor VIIIa and the serine protease domain of factor X identified by zero-length cross-linking. Thromb Haemost 80:418-422.
28. Lenting PJ, Donath MJSH, van Mourik JA, et al.: 1994. Identification of a binding site for blood coagulation factor IXa on the light chain of human factor VIII. J Biol Chem 269:7150-7155.
29. Lenting PJ, van de Loo J-WHP, Donath M-JSH, et al: 1996. The sequence Glu1811-Lys1818 of human blood coagulation factor VIII comprises a binding site for activated factor IX. J Biol Chem 271:1935-1940.
30. Leyte A, van Schijndel HB, Niehrs C, et al.: 1991. Sulfation of tyr1680 of human blood coagulation factor VIII is essential for the interaction of factor VIII with von Willebrand factor. J Biol Chem 266:740-746.
31. Lollar P, Knutson GJ, Pass DN: 1984. Stabilization of thrombin-activated porcine factor VIII:C by factor IXa phospholipid. Blood 63:1303-1308.
32. Lollar P, Knutson GJ, Pass DN: 1985. Activation of porcine factor VIII:C by thrombin and factor Xa. Biochemistry 24:8056-8064.
33. Lollar P, Parker CG: 1990. pH-dependent denaturation of thrombin-activated porcine factor VIII. J Biol Chem 265:1688-1692.
34. Lollar P, Parker ET, Fay PJ: 1992. Coagulant properties of hybrid human/porcine factor VIII molecules. J Biol Chem 267:23,652-23,657.
35. London F, Walsh PN: 1996. The role of electrostatic interactions in the assembly of the factor X activating complex on both activated platelets and negatively-charged phospholipid vesicles. Biochemistry 35:12,146-12,154.
36. Lu D, Kalafatis M, Mann KG, et al.: 1996. Comparison of activated protein C/protein S-mediated inactivation of human factor VIII and factor V. Blood 87:4708-4717.
37. Mathur A, Zhong D, Sabharwal AK, et al.: 1997. Interaction of Factor IXa with Factor VIIIa. J Biol Chem 272:23,418-23,426.
38. McGee MP, Li LC: 1991. Functional difference between intrinsic and extrinsic coagulation pathways. J Biol Chem 266:8079-8085.
39. McGee MP, Li LC, Hensler M: 1992. Functional assembly of intrinsic coagulation proteases on monocytes and platelets. Comparison between cofactor activities induced by thrombin and factor Xa. J Exp Med 176:27-35.
40. Nesheim M, Pittman DD, Giles AR, et al.: 1991. The effect of plasma von Willebrand factor on the binding of human factor VIII to thrombin-activated human platelets. J Biol Chem 266:17,815-17,820.
41. 35S-labeled recombinant factor VIII to activated and unactivated human platelets. J Biol Chem 263:16,467-16,470.
42. Nogami K, Shima M, Hosokawa K, et al.: 1999. Role of factor VIII C2 domain in factor VIII binding to factor Xa. J Biol Chem 274:31,000-31,007.
43. Ortel TL, Moore KD, Quinn-Allen MA, et al.: 1998. Inhibitory anti-factor V antibodies bind to the factor V C2 domain and are associated with hemorrhagic infections. Blood 91:4188-4196.
44. Pemberton S, Lindley P, Zaitsev V, et al: 1997. A molecular model for the triplicated A domains of human factor VIII based on the crystal structure of human ceruloplasmin. Blood 89:2413-2421.
45. Pipe SW, Kaufman RJ: 1997. Characterization of a genetically engineered inactivation-resistant coagulation factor Villa. Proc Natl Acad Sci USA 94:11,851-11,656.
46. Pittman DD, Kaufman RJ: 1988. Proteolytic requirements for thrombin activation of anti-hemophilic factor (factor VIII). Proc Natl Acad Sci USA 85:2429-2433.
47. Pratt KP, Fujikawa K, Takeshima K, et al.: 1999. Crystal structure of the factor VIII C2 domain. Thromb Haemost 82(Suppl):234.
48. Regan LM, Fay PJ: 1995. Cleavage of factor VIII light chain is required for maximal generation of factor Villa activity. J Biol Chem 270:8546-8552.
49. Regan LM, O'Brien LM, Beattie TL, et al.: 1996. Activated protein C-catalyzed proteolysis of factor VIIIa alters its interactions within factor Xase. J Biol Chem 271:3982-3987.
50. Saenko EL, Scandella D: 1995. A mechanism for inhibition of factor VIII binding to phospholipid by von Willebrand factor. J Biol Chem 270:13,826-13,833.
51. Saenko EL, Scandella D: 1997. The acidic region of the light chain and the C2 domain together form a high affinity binding site for von Willebrand factor. J Biol Chem 272:18,007-18,014.
52. Saenko EL, Scandella D, Yakhyaev AV, et al.: 1998. Activation of factor VIII by thrombin increases its affinity for binding to synthetic phospholipid membranes and activated platelets. J Biol Chem 273:27,918-27,926.
53. Saenko EL, Shima M, Gilbert GE, et al.: 1996. Slowed release of thrombin-cleaved factor VIII from von Willebrand factor by a monoclonal and a human antibody is a novel mechanism for factor VIII inhibition. J Biol Chem 271:27,424-27,431.
54. Saenko EL, Shima M, Rajalakshmi KJ, et al.: 1994. A role for the C2 domain of factor VIII in binding to von Willebrand factor. J Biol Chem 269:11,601-11,605.
55. Spaargaren J, Giessen PLA, Janssen MP, et al.: 1995. Binding of blood coagulation factor VIII and its light chain to phosphatidylserine/phosphatidylcholine bilayers as measured by ellipsometry. Biochem J 310:539-545.
56. Takeshima K, Fujikawa K: 1999. The phospholipid binding property of the C2 domain of human factor VIII. Thromb Haemost 82(Suppl):234.
57. Van Dieijen G, Tans G, Rosing J, et al.: 1981. The role of phospholipid and factor VIIIa in the activation of bovine factor X. J Biol Chem 256:3433-3442.
58. Vehar GA, Keyt B, Eaton D, et al.: 1984. Structure of human factor VIII. Nature 312:337-340.
59. Vlot AJ, Koppelman SJ, van den Berg MH, et al.: 1995. The affinity and stoichiometry of binding of human factor VIII to von Willebrand factor. Blood 85:3150-3157.
60. Wion K, Kelly D, Summerfield JA, et al.: 1985. Distribution of factor VIII mRNA and antigen in human liver and other tissues. Nature 317:726-730.